Compile Data Set for Download or QSAR
Found 152 for UniProtKB: Q9HCE5
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM612842(US11725010, Example 1)
Affinity DataIC50:  3.84nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613292(US11725010, Example 155)
Affinity DataIC50: <6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM612843(BDBM613184 | US11725010, Example 2)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM612844(N-[[2-[[(3,3- difluorocyclobutyl) methylamino] met...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM612846(N-[[2-[[(1- hydroxycyclobutyl) methylamino] methyl...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM612848(US11725010, Example 6)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM612858(N-[[2-[(1- adamantylamino) methyl]-1H- indol-6- yl...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM612884(N-[[2-[[(1- hydroxycyclo- pentyl) methylamino] met...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613160(N-[(2-{[({3- fluorobicyclo[1.1.1] pentan-1- yl}met...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613163(N-[[2- [(cyclopentyl- amino)methyl]- 1H-indol-6- y...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613164(N-[[2- [(cyclopentyl- methylamino) methyl]-1H-indo...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613167(N-[[2- [(cyclohexylamino) methyl]- 1H-indol-6- yl]...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613171(N-[[2-[(2,2- dimethylpropyl- amino)methyl]- 1H-ind...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613172(N-[[2-[(1- bicyclo[1.1.1] pentanylmethyl- amino)me...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613173(N-{[2- ({[(1S,2S)-2- hydroxycyclo- pentyl]amino} m...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613175(N-{[2- ({[(1S,2R)-2- hydroxycyclo- pentyl]amino} m...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613178(N-[[2- [(cyclobutyl- methylamino) methyl]-5-fluoro...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613182(US11725010, Example 45)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM612843(BDBM613184 | US11725010, Example 2)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613192(N-[[6-[[4- (1H-indazol- 4-yl)triazol- 1-yl]methyl]...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613194(1-[[[6-[[4- (1H-indazol- 4-yl)triazol- 1-yl]methyl...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613195(US11725010, Example 58)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613196(US11725010, Example 59)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613197(US11725010, Example 60)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613199(US11725010, Example 62)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613204(N-[[2-(2- azaspiro[3.3] heptanean-2- ylmethyl)-1H-...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613213(N-[(2- {[({bicyclo[2.1.1] hexan-1- yl}methyl)amino...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613214(N-[(2-{[({3- methylbicyclo [1.1.1]pentan-1- yl}met...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613218(N-{[2-({2- azaspiro[3.4] octan-2- yl}methyl)-1H- i...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613227(N-{[2-({2- azaspiro[3.5] nonan-2- yl}methyl)-1H- i...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613229(4-(1-{[2-({2- azaspiro[3.3] heptanean- 2-yl}methyl...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613232(N-({2-[(3,3- dimethylpyrrolidin- 1-yl)methyl]-1H- ...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613233(N-{[2-({6- fluoro-2- azaspiro[3.3] heptanean-2- yl...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613234(N-{[2-({6,6- difluoro-2- azaspiro[3.3] heptanean-2...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613235(N-({2-[(3- cyclobutylazetidin- 1-yl)methyl]-1H- in...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613241(US11725010, Example 124)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613243(N-({2-[(3,3- diethylazetidin- 1-yl)methyl]- 1H-ind...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613246(US11725010, Example 114)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613247(N-{[2-({6- azaspiro[3.4] octan-6- yl}methyl)-1H- i...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613248(N-[(2-{[(1- cyclobutylcyclo- propyl)amino] methyl}...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613250(N-{[2- ({octahydro- cyclopenta[c] pyrrol-2-yl}meth...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613251(N-[(2-{[(1-{3- fluorobicyclo [1.1.1]pentan-1- yl}e...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613252(N-{[2-({[(1- methylcyclobutyl) methyl]amino} methy...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613257(US11725010, Example 125)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613258(N-{[2-({2- azaspiro[4.4] nonan-2- yl}methyl)-1H- i...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613262(4-oxo-N-({2- [({spiro[2.3] hexan-1- yl}amino)methy...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613263(4-oxo-N-[(2- {[({spiro[2.2] pentan-1- yl}methyl)am...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613264(N-[(2-{[({3- methylbicyclo[1.1.1] pentan-1- yl}met...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613265(N-[(2- {[(cyclobutylmethyl) amino]methyl}-1H- pyrr...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Homo sapiens)
Storm Therapeutics Limited

US Patent
LigandPNGBDBM613266(N-[(2- {[({bicyclo[1.1.1] pentan-1- yl}methyl)amin...)
Affinity DataIC50:  6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 152 total ) | Next | Last >>
Jump to: